Download PDF
J Pediatr Infect Dis 2023; 18(05): 240-244
DOI: 10.1055/s-0043-1769121
Original Article

Evaluation of Ocular Findings Following Multisystem Inflammatory Syndrome in Children

Aslıhan Sahin 
1   Division of Paediatric Infectious Diseases, Health Sciences University Tepecik Training and Research Hospital, Izmir, Türkiye
,
Emine Kaya-Guner
2   Department of Ophthalmology, Health Sciences University Tepecik Training and Research Hospital, Izmir, Türkiye
,
Yıldız Ekemen-Keles
1   Division of Paediatric Infectious Diseases, Health Sciences University Tepecik Training and Research Hospital, Izmir, Türkiye
,
Eda Karadag-Oncel
1   Division of Paediatric Infectious Diseases, Health Sciences University Tepecik Training and Research Hospital, Izmir, Türkiye
,
Ahu Kara-Aksay
1   Division of Paediatric Infectious Diseases, Health Sciences University Tepecik Training and Research Hospital, Izmir, Türkiye
,
Dilek Yilmaz
1   Division of Paediatric Infectious Diseases, Health Sciences University Tepecik Training and Research Hospital, Izmir, Türkiye
3   Division of Paediatric Infectious Diseases, Department of Paediatrics, Izmir Katip Celebi University Faculty of Medicine, Izmir, Türkiye
› Author Affiliations
› Further Information
    Permissions and Reprints

Abstract

Objective Multisystem inflammatory syndrome (MIS-C) in children is associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and can be mortal with the involvement of multiple organ systems. However, long-term effects on all organs and organ systems involvement are still unclear or even whether this condition may still occur in which organs. This report aims to identify ocular findings in children with MIS-C on the follow-up.

Methods This is a prospective cross-sectional study. Cases diagnosed with MIS-C between May 2020 and February 2021 in our hospital (e.g., cases aged 1 month–18 years old) were included in the study. The same ophthalmologist followed up with the patients after discharge. Patients underwent detailed ophthalmic examinations, including slit lamp biomicroscopy and fundoscopy, best-corrected visual acuity, and Schirmer's 2 test.

Results Our study included 22 patients treated with the MIS-C. Twelve (54.5%) were girls, and 10 (45.5%) were boys. Their mean age was 8.7 ± 4.9 years. Pathological ocular findings were found in six (27.2%) patients in the follow-up. The most common finding was punctate epitheliopathy in four (18.2%) patients. The cause of punctate epitheliopathy was dry eye. All patients recovered with treatment.

Conclusion Our study is the first to evaluate ocular findings in MIS-C in the long term. Regardless of the severity of the disease, the most common ocular finding in our study was punctate epitheliopathy, that is, dry eye. According to our results, we think patients should be followed up on pathological ocular findings after discharge.

Keywords

dry eye - multisystem inflammatory syndrome - ophthalmic examinations punctate epitheliopathy - SARS-CoV-2


Publication History

Received: 18 January 2023

Accepted: 19 April 2023

Article published online:
23 May 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Lu X, Zhang L, Du H. et al; Chinese Pediatric Novel Coronavirus Study Team. SARS-CoV-2 infection in children. N Engl J Med 2020; 382 (17) 1663-1665
    CrossrefPubMedGoogle Scholar
  • 2 Whittaker E, Bamford A, Kenny J. et al; PIMS-TS Study Group and EUCLIDS and PERFORM Consortia. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA 2020; 324 (03) 259-269
    CrossrefPubMedGoogle Scholar
  • 3 European Centre for Disease Prevention and Control. Paediatric Inflammatory Multisystem Syndrome and SARS-CoV-2 Infection in Children, 18. Stockholm: The Centre; 2020
    Google Scholar
  • 4 WHO Global. Multisystem Inflammatory Syndrome in Children and Adolescents with COVID-19. Geneva: World Health Organization; 2020. Report No.: WHO/2019-nCoV/Sci_Brief/Multisystem_Syndrome_Children/2020.1. Accessed April 28, 2023 at: https://www.who.int/news-room/commentaries/detail/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19
    Google Scholar
  • 5 Centers for Disease Control and Prevention. Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with Coronavirus Disease 2019 (COVID-19). Accessed April 28, 2023 at https://www.cdc.gov/mmwr/volumes/69/wr/mm6932e2.htm
  • 6 Maddux AB, Berbert L, Young CC. et al; Overcoming COVID-19 Investigators. Health impairments in children and adolescents after hospitalization for acute COVID-19 or MIS-C. Pediatrics 2022; 150 (03) e2022057798
    CrossrefPubMedGoogle Scholar
  • 7 Penner J, Abdel-Mannan O, Grant K. et al; GOSH PIMS-TS MDT Group. 6-month multidisciplinary follow-up and outcomes of patients with paediatric inflammatory multisystem syndrome (PIMS-TS) at a UK tertiary paediatric hospital: a retrospective cohort study. Lancet Child Adolesc Health 2021; 5 (07) 473-482
    CrossrefPubMedGoogle Scholar
  • 8 Lo TC, Chen YY. Ocular and systemic manifestations in paediatric multisystem inflammatory syndrome associated with COVID-19. J Clin Med 2021; 10 (13) 2953
    CrossrefPubMedGoogle Scholar
  • 9 Merticariu CI, Merticariu M, Cobzariu C, Mihai MM, Dragomir MS. Pediatric inflammatory multisystem syndrome induced panuveitis associated with SARS-CoV- 2 infection: what the ophthalmologists need to know. Rom J Ophthalmol 2022; 66 (02) 198-208
    PubMedGoogle Scholar
  • 10 Kurumoğlu Incekalan T, Celik U, Tolunay O, Naz Şimdivar GH, Alyamaç Sukgen E. Changes in retinal and choroidal capillary dynamics in patients with multisystem inflammatory syndrome in children. Int Ophthalmol 2023; 43 (01) 3-12
    CrossrefPubMedGoogle Scholar
  • 11 Devebacak A, Biler ED. Optic disc involvement in multisystem inflammatory syndrome in children secondary to COVID-19. J Neuroophthalmol 2022
    PubMedGoogle Scholar
  • 12 Altunisik Toplu S, Ersoy Y, Bayindir Y, Kilic T, Bayazit V. Multisystem inflammatory syndrome in adults (MIS-A) associated with SARS-CoV-2 infection in a young adult case from Türkiye. Medeniyet Med J 2021; 36 (02) 180-184
    PubMedGoogle Scholar
  • 13 Kunal S, Ish P, Sakthivel P, Malhotra N, Gupta K. The emerging threat of multisystem inflammatory syndrome in adults (MIS-A) in COVID-19: a systematic review. Heart Lung 2022; 54: 7-18
    CrossrefPubMedGoogle Scholar
  • 14 Cetin BS, Kısaarslan AP, Baykan A, Akyıldız BN, Poyrazoglu H. Erciyes Clinical Guideline for Multisystem Inflammatory Syndrome in Children (MIS-C) associated with COVID-19: Erciyes MIS-C Guideline. JPA 2022
    PubMedGoogle Scholar
  • 15 Yasuhara J, Watanabe K, Takagi H, Sumitomo N, Kuno T. COVID-19 and multisystem inflammatory syndrome in children: a systematic review and meta-analysis. Pediatr Pulmonol 2021; 56 (05) 837-848
    CrossrefPubMedGoogle Scholar
  • 16 Holland EJ, Mannis MJ, Lee WB. Ocular Surface Disease: Cornea, Conjunctiva, and Tear Film. London: Elsevier/Saunders; 2013
    Google Scholar
  • 17 Hong N, Yu W, Xia J, Shen Y, Yap M, Han W. Evaluation of ocular symptoms and tropism of SARS-CoV-2 in patients confirmed with COVID-19. Acta Ophthalmol 2020; 98 (05) e649-e655
    CrossrefPubMedGoogle Scholar
  • 18 Chen L, Deng C, Chen X. et al. Ocular manifestations and clinical characteristics of 535 cases of COVID-19 in Wuhan, China: a cross-sectional study. Acta Ophthalmol 2020; 98 (08) e951-e959
    CrossrefPubMedGoogle Scholar
  • 19 Dana R, Bradley JL, Guerin A. et al. Estimated prevalence and incidence of dry eye disease based on coding analysis of a large, all-age united states health care system. Am J Ophthalmol 2019; 202: 47-54
    CrossrefPubMedGoogle Scholar
  • 20 Huang R, Su C, Fang L, Lu J, Chen J, Ding Y. Dry eye syndrome: comprehensive etiologies and recent clinical trials. Int Ophthalmol 2022; 42 (10) 3253-3272
    CrossrefPubMedGoogle Scholar
  • 21 Wong Chung JERE, Engin Ö, Wolfs TFW, Renson TJC, de Boer JH. Anterior uveitis in paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. Lancet 2021; 397 (10281): e10
    CrossrefPubMedGoogle Scholar
  • 22 Öztürk C, Yüce Sezen A, Savaş Şen Z, Özdem S. Bilateral acute anterior uveitis and corneal punctate epitheliopathy in children diagnosed with multisystem inflammatory syndrome secondary to COVID-19. Ocul Immunol Inflamm 2021; 29 (04) 700-704
    CrossrefPubMedGoogle Scholar
  • 23 Alonso RS, Alonso FOM, Fernandes BF, Ecard VO, Ventura MP. COVID-19-related ocular hypertension secondary to anterior uveitis as part of a multisystemic inflammatory syndrome. J Glaucoma 2021; 30 (05) e256-e258
    CrossrefPubMedGoogle Scholar
  • 24 Karthika IK, Gulla KM, John J. et al. COVID-19 related multi-inflammatory syndrome presenting with uveitis: a case report. Indian J Ophthalmol 2021; 69 (05) 1319-1321
    CrossrefPubMedGoogle Scholar
  • 25 Hookham L, Teoh P, Stern W, Goodman AL. Can PIMS-TS lead to a facial nerve palsy?. BMJ Case Rep 2021; 14 (06) e242887
    CrossrefPubMedGoogle Scholar
  • 26 Sim AYC, Naffi AA, Fai TS. et al. Bilateral intermediate uveitis in a healthy teenager with the multisystem inflammatory syndrome in children secondary to COVID-19 infection. J Med Virol 2022; 94 (04) 1269-1271
    CrossrefPubMedGoogle Scholar
  • 27 Savas Sen Z, Tanir G, Gumuser Cinni R. et al. Multisystem inflammatory syndrome in children during severe acute respiratory syndrome coronavirus-2 pandemic in Türkiye: a single-centre experience. J Paediatr Child Health 2022; 58 (01) 129-135
    CrossrefPubMedGoogle Scholar
  • 28 Dinkin M, Segal D, Zyskind I, Oliveira C, Liu G. Bilateral optic disc edema in multisystem inflammatory syndrome in children associated with COVID-19. J Neuroophthalmol 2022; 42 (01) e318-e322
    CrossrefPubMedGoogle Scholar
  • 29 Gerding R. Kawasaki disease: a review. J Pediatr Health Care 2011; 25 (06) 379-387
    CrossrefPubMedGoogle Scholar
  • 30 Madhusudan S, Singh S, Suri D, Gupta A, Gupta A. Acute anterior uveitis as the presenting feature of Kawasaki disease. Indian J Pediatr 2014; 81 (04) 415
    CrossrefPubMedGoogle Scholar
  • 31 Shiari R, Jari M, Karimi S. et al. Relationship between ocular involvement and clinical manifestations, laboratory findings, and coronary artery dilatation in Kawasaki disease. Eye (Lond) 2020; 34 (10) 1883-1887
    CrossrefPubMedGoogle Scholar
  • 32 Choi HS, Lee SB, Kwon JH, Kim HS, Sohn S, Hong YM. Uveitis as an important ocular sign to help early diagnosis in Kawasaki disease. Korean J Pediatr 2015; 58 (10) 374-379
    CrossrefPubMedGoogle Scholar